Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

T Cohen, Alexander; E. Spiro, Theodore; R. Büller, Harry; Haskell, Lloyd; Hu, Dayi; D. Hull, Russell; Mebazaa, Alexandre; J. Merli, Geno; Schellong, Sebastian; C. Spyropoulos, Alex; F. Tapson, Victor

doi:10.1056/nejmoa1111096

Public

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

Published in New England Journal of Medicine • Feb 6, 2013

Authors:

Alexander T Cohen

Theodore E. Spiro

Harry R. Büller

Abstract

BACKGROUND: The clinically appropriate duration of thromboprophylaxis in hospitalized patients with acute medical illnesses is unknown. In this multicenter, randomized, double-blind trial, we evaluated the efficacy and safety of oral rivaroxaban administered for an extended period, as compared with ...

Subject

Medicine

Rivaroxaban

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!